Bone Health in Cancer Survivors

Course Overview

The incidence of fractures from osteoporosis is larger than the incidence of heart attacks, strokes, and breast cancer – combined. It's estimated that 35 million American women will have either osteoporosis or low bone mass at some point in their lives. Certain conditions, including cancer and its treatments, can make bones fragile and more likely to break. "Osteoporosis is defined as a silent disease. You don't know about it or have any symptoms unless you actually fracture," says Dr. Mimi Hu, Assistant Professor of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center.

     Course Overview: Español



Mimi Hu, M.D.
Bone Health in Cancer Survivors
Presenter: Mimi Hu, M.D.
Assistant Professor
Department of Endocrine Neoplasia and Hormonal Disorders

Summary: In her first lecture, "Bone Health in Cancer Survivors, Part 1", Dr. Hu describes the manifestations of low bone density and osteoporosis, identifies the risk factors for bone loss, assesses tools for evaluating low bone mass, and talks about the effects of cancer treatment on bone health. She specifically reviews the findings of several key studies on the causes of bone loss after cancer treatment. The lecture focuses on bone health in breast and prostate cancer survivors. The second part of Dr. Hu's lecture, "Bone Health in Cancer Survivors, Part 2", focuses on evaluating treatments that are available for preventing and treating low bone density and identifying long-term surveillance programs for bone health in cancer survivors.



For further information or assistance, to provide feedback on this web site, or to request a specific professional oncology education topic, please e-mail Professional Oncology Education.

Course Options